Impact of non-compliance on the cost-effectiveness of statin therapy

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

StandardStandard

Impact of non-compliance on the cost-effectiveness of statin therapy. / Hughes, D.; Hughes, D.A.; Bagust, A.
Yn: Value in Health, Cyfrol 4, Rhif 6, 01.09.2001, t. 489.

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

HarvardHarvard

Hughes, D, Hughes, DA & Bagust, A 2001, 'Impact of non-compliance on the cost-effectiveness of statin therapy', Value in Health, cyfrol. 4, rhif 6, tt. 489.

APA

Hughes, D., Hughes, D. A., & Bagust, A. (2001). Impact of non-compliance on the cost-effectiveness of statin therapy. Value in Health, 4(6), 489.

CBE

Hughes D, Hughes DA, Bagust A. 2001. Impact of non-compliance on the cost-effectiveness of statin therapy. Value in Health. 4(6):489.

MLA

Hughes, D., D.A. Hughes a A. Bagust. "Impact of non-compliance on the cost-effectiveness of statin therapy". Value in Health. 2001, 4(6). 489.

VancouverVancouver

Hughes D, Hughes DA, Bagust A. Impact of non-compliance on the cost-effectiveness of statin therapy. Value in Health. 2001 Medi 1;4(6):489.

Author

Hughes, D. ; Hughes, D.A. ; Bagust, A. / Impact of non-compliance on the cost-effectiveness of statin therapy. Yn: Value in Health. 2001 ; Cyfrol 4, Rhif 6. tt. 489.

RIS

TY - JOUR

T1 - Impact of non-compliance on the cost-effectiveness of statin therapy

AU - Hughes, D.

AU - Hughes, D.A.

AU - Bagust, A.

PY - 2001/9/1

Y1 - 2001/9/1

M3 - Article

VL - 4

SP - 489

JO - Value in Health

JF - Value in Health

SN - 1524-4733

IS - 6

ER -